Leading the Way in Life Science Technologies

GEN Exclusives

More »

November 1, Vol. 36, No. 19

  • Feature Articles

    • Toward Troubleshooting the Connectome
    • Richard A. Stein
    • Throughout the history of functional morphology, the brain was less forthcoming than many other organs The brain was particularly challenging to early researchers, who often had to resort to the study of anomalies—illness- or trauma-related morphological changes, which might be ... more »
    • Expedited Delivery of RNAi Therapeutics
    • Angela Zimmermann
    • The field of RNA interference (RNAi) therapy has strategically circumvented persistent technical challenges, which effectively extinguished hyperbolic expectations in the early days of development Now, with advances in delivery and clinical trials underway, RNAi is making strides toward silencing ... more »
    • The New Bioassay Frontier
    • MaryAnn Labant
    • Bioassays are scientific experiments involving the use of cell cultures, tissue preparations, or living animals or plants to determine the biological activity of a substance, such as a hormone or drug Due to the inherent variability of the testing platform, ... more »
    • Priming Cell Lines for Peak Performance
    • Angelo DePalma
    • The global cell-line development market will keep growing, says MarketsandMarkets, which projects that cell-line development products—equipment, media, and reagents—will reach $40 billion in value by 2019, up from $22 billion in 2014, reflecting a compound annual growth rate of about ... more »